Skip to main content
OpenTrials

Clinical trial condition

Togaviridae Infections

Explore clinical trials studying Togaviridae Infections. Study availability and eligibility vary by location and protocol.

146 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Togaviridae Infections trial results

Completed

Trial for Safety and Immunogenicity of a Chikungunya Vaccine, VRC-CHKVLP059-00-VP, in Healthy Adults

NCT02562482

Conditions
Alphavirus Infections, Arbovirus Infections, Chikungunya Fever, +7 more
Locations
  • Instituto Dermatológico y Cirugía de Piel Santo Domingo, Dominican Republic
  • University Hospital of Pointe-à-Pitre Pointe-à-Pitre, Guadeloupe
  • Centres GHESKIO Port-au-Prince, Haiti
  • Centre Hospitalier Universitaire (CHU), Martinique Fort-de-France, Martinique
View Trial Details
Completed

Neurologic Manifestations of the Arbovirus Infection in Colombia

NCT03206541

Conditions
Alphavirus Infections, Arbovirus Infections, Autoimmune Diseases, +40 more
Locations
  • Clinica Leon XIII Medellín, Antioquia, Colombia
  • Neuroclinica Medellín, Antioquia, Colombia
  • Clinica La Misericordia Internacional Barranquilla, Atlántico, Colombia
  • Hospital Universitario de Narino Pasto, Departamento de Nariño, Colombia
View Trial Details
Completed

Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age

NCT00861744

Conditions
Infections, Measles, Measles-Mumps-Rubella Vaccine, +15 more
Locations
  • GSK Investigational Site Tuscaloosa, Alabama, United States
  • GSK Investigational Site Conway, Arkansas, United States
  • GSK Investigational Site Jonesboro, Arkansas, United States
  • GSK Investigational Site Little Rock, Arkansas, United States
View all 48 locations
View Trial Details
Completed

Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M-M-R II), in Children 12 to 15 Months of Age

NCT01702428

Conditions
Infections, Measles, Mononegavirales Infections, +14 more
Locations
  • GSK Investigational Site Dothan, Alabama, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Fayetteville, Arkansas, United States
  • GSK Investigational Site Anaheim, California, United States
View all 90 locations
View Trial Details

Related conditions